Your basket is currently empty!
ProM2® MHC Class II Monomers - Catalog
| Allele | Peptide Code | Peptide Sequence | Application | Epitope Origin |
|---|---|---|---|---|
-- All Alleles -- A*01:01 A*02:01 A*02:01/Kb A*02:03 A*02:06 A*03:01 A*11:01 A*11:03 A*24:02 A*29:02 A*68:01 B*07:02 B*08:01 B*14:02 B*15:01 B*27:05 B*35:01 B*35:08 B*40:01 B*54:01 C*06:02 C*07:02 DRA1*01:01 / DRB1*04:01 DRA1*01:01 / DRB1*07:01 DRA1*01:01 / DRB1*15:01 DRA1*01:01/DRB1*01:01 DRA1*01:01/DRB1*03:01 DRA1*01:01/DRB1*03:01 DRA1*01:01/DRB1*04:01 DRA1*01:01/DRB1*04:02 DRA1*01:01/DRB1*04:05 DRA1*01:01/DRB1*07:01 DRA1*01:01/DRB1*09:01 DRA1*01:01/DRB1*11:01 DRA1*01:01/DRB1*15:01 DRB1*01:01 DRB1*03:01 DRB1*07:01 DRB1*15:01 E*01:01 H-2 IAb H-2 IAd H-2 IAg7 H-2Db H-2Dd H-2Dk H-2IAb H-2IAd H-2IAg7 H-2Kb H-2Kd H-2Kk H-2Ld H2-Kd IAg7 Mamu-A*01 Mamu-A*02 | -- All Peptide Codes -- 008 049 082 1 10 1013 1043 1056 1064 1066 107 1072 109 1094 1107 1110 1111 1112 1113 1126 114 1147 1152 1153 117 118 1181 1182 119 120 1201 1211 1239 1240 125 1263 127 129 1303 1320 1322 1327 133 1333 1346 1386 1403 142 1421 1431 144 1464 1486 149 1496 150 1508 1509 151 1536 154 157 158 1598 1599 1616 163 1684 1686 171 172 1720 1722 1731 174 1743 1744 175 176 177 1778 178 1780 1786 1803 1805 1806 1838 185 186 188 190 1904 1908 1910 1912 1915 1920 193 1937 194 1940 1941 1942 1945 195 196 198 199 2 200 202A 202B 202C 205 2064 2065 2067 2076 2079 208 2081 2083 209 2097 21 210 2103 212 214 2156 2167 2198 2199 2205 2206 2221 2259 2282 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 23 230 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 231 2310 2311 2312 2313 2331 2355 2369 237 2371 238 2382 240 242 246 249 250 255 2560 257 2585 264 266 269 2690 2691 2693 2695 2697 2699 27 2701 2702 2703 2705 2706 2707 2712 2712A 2712B 2714 2715 2716 2717 2718A 2718B 2718C 2719 2720 2721 2722 2723 2725 2727 2728 2729 2733 2734 2735 2736A 2736B 2736C 2737 2738 2739 2740 2741 2742 2754 2755 276 278 28 2829 283 2882 2883 2884 2887 2888 2889 2890 2891 2892 2893 2894A 2894B 2895 2896A 2896B 2896C 2897 2898A 2898B 2898C 2899 29 2900 2901 2902 294 2951 2963 2988 2990 3 30 302 3033 307 308 31 3115 3131 3132 3133 3134 3135 3136 3137 3138 3139 314 3140 3143 3144 3145 3146 3147 3148 3149 3151 3152 3153A 3153B 3155 3156 3157 3158 3159 3161 3162 3163A 3163B 3163C 3163D 3163E 3163F 3164A 3164B 3165 3166 3167 32 3215 3238 3239 324 3240 3242A 3242B 3243A 3243B 3243C 3244A 3244B 327 328 329 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 3360 3361 3362 3363 3364 3365 3366 3367 3368 3369 3370 3371 3372 3373 3374 3375 3376 3377 3379 338 3380 3381 3382 3383 3384 3385 3386 3387 3388 3389 339 3390 3391 3392 3394 3396 3397 3398 34 3400 3401 3402 3403 3404 3405A 3405B 3406 3407 3408 3409 3410 3411 3412 3414 3415 3416 3418 3419 3420 3421 3422 343 35 351 353 357A 357B 357C 357D 357E 357F 36 366 37 373 376 377 378 3781 380 381 389 390 391 393 394 395 3955 398 399 4 40 403 404 405 409 410 411 4129 413 414 415 417 418 419 42 420 421 422 424 4250 4295 430 4320 4356A 44 447 45 452 458 46 462 463 464 468 4683A 4683B 4683C 47 470 473 477 479 48 480 485 488 489 49 491 502H 508 527 540 541 543 547 549 550 552 559 56 560 561 562 565 57 575 58 581 594 599 600 61 610 611 615 619 62 620 622 628 639 645 646 647 648 651 652 654 658 663 666 683 684 685 686 689 69 690 692 695 7 70 703 708 712 719 721 726 727 73 733 739 74 740 742 75 76 764 769 77 771 773 774 780 781 791 799 8 801 810 811 813 814 82 822 828 84 840 841 845 85 851 858 859 86 860 861 862 87 871 872 874 877 879 884 886 893 9 908 915 93 939 94 942 95 954 958 960 964 97 978 98 989 995 N01 N02A N02B N02C N02D N02E N02F N02G N02H N02I 001 002 003 004 007 009 010 021 023 027 028 029 030 031 032 034 035 036 037 040 042 044 045 046 047 048 056 057 058 061 062 069 070 073 074 075 076 077 084 085 086 087 093 094 095 097 098 1007 1010 1130 1194 1244 1246 1302 1321 1324 1513 1516 1542 162 164 1779 1783 1843 2070 2102 2164 2194 220 221 2236 2257 226 2372 2373 2415 243 2457 2569 2582 2649 2659 2669 2675 2778 2793 2844 2858 2860 2929 2950 2954 2958 3006 3023 3024 3027 3028 3029 304 3041 3043 3051 306 3070 3072 3080 3092 3094 3214 3223A 3223B 3264 3269 334 335 337 3417 3423 3436 345 3459 3460 3461 3462 3622 3623 3624 3626 3627 3628 3630 3632 3633 3634 3636 3638 3641 3643 3644 3647 3648 3649 3654 3655 3656 3658 3659 3660 3661 3662 3666 3668 3669 3670 3671 3673 3674 3675 3678 3680 3681 3684 3687 3688 3689 3691 3693 3695 3696 3698 3699 370 3702 3704 3705 3706 3708 3709 3710 3711 3713 3715 3718 3719 3720 3721 3722 3723 3724 3725 3726 3728 3730 3731 3732 3733 3734 3735 3736 3744 3903 3906 3907 3908 3909 3910A 3910B 3912 3913 3914 3915 3916A 3916B 3918 3921A 3921B 3923 3924 3925 3928 3929A 3929B 3931 3934 3935 3937 3939 3941 3942 3943 3945 3947 408 4081 4082 4083 4117 4118 4119 4122 4123 4124 4125 4131 4132 4133 4135 4136 4137 4183 4186 4187 423 4268 4269 4270 4271 4272 4273 4294A 4294B 4321 4322 4323 4324 4326 4328 4329 4330 4331A 4331B 4332 4333 4339 4340 4342 4351 4354 4355 4356B 4358 4381 4382 4404 4405 4406 4407 4414 4418 4443 4501 4544 4549 457 4625 4626 4627 4628 4629 4630 4631 4632 4633 4634 4668 467 4670 4679 4690 4691A 4691B 4692 4694 4702A 4702B 4702C 4703A 4703B 4703C 4704A 4704B 4704C 4705A 4705B 4705C 4724 4725 4726 4894 500 516 526 529 580 637 655 662 693 701 752 778 785 787 921 922 969 997 998 N02J N02K N02L N02M | -- All Peptide Sequences -- AAHAEINEA AAVKNWMTQTL Abu-Abu-L-Abu-LTVFL ACQGVGGPGHK ACYEFLWGPRALVETS AEGLRALLARSHVER AFLPWHRLF AFSPEVIPMFSALSEGATPQ AGPHNDMEI AGPPRYSRI AGVDNRECI AHHPIWARMDA AIFQSSMTK AIKRGLRTL AILALLPAL AILALLPALL AIQDLCLAV AIQDLCVAV AIQGNVTSI AITEVECFL AKFVAAWTLKAA AKRLDACQDQLLE ALCNTDSPL ALDVYNGLL ALFDIESKV ALGGHPLLGV ALHIYMDGTMSQVQGSA ALIHHNTHL ALKDVEERV ALLAGLVSL ALLAVGATK ALLPAVPSL ALLTSRLRFI ALLTYMIAHI ALMDKSLHV ALMEQQHYV ALNTLVKQL ALNVYNGLL ALPFGFILV ALPHIIDEV ALPPPLMLL ALQPGTALL ALSPVPPVV ALSVMGVYV ALTPVVVTL ALVCYGPGI ALVEFEDVL ALVEMGHHA ALWALPHAA ALWGPDPAAA ALWPWLLMA ALWPWLLMAT ALYDVVTKL ALYLMELTM ALYVDSLFFL AMASTEGNV AMLGTHTMEV AMQMLKDTI AMQMLKETI AMVGAVLTA ANYNFTLV APRGVRMAV APTRVVAAEM APYHFDLSGHAFG AQLANDVVL ARKLLLDNL ARMILMTHF ASFRNLTHL ASFVNPIYL ASMTNMELM ASNENMDAM ASNENMETM ATDALMTGF ATDALMTGY ATEG[cit]V[cit]VNSAYQDK ATFKNWPFL ATGFKQSSK ATIGTAMYK ATIKAEFV[cit]AETPYM ATLTYRML ATVGIMIGV ATVLMGLGK ATWAENIQV ATYGWNLVK AVDLSHFLK AVFDRKSDAK AVIGALLAV AVLDGLLSL AVLPLLELV AVNIVGYSNAQGVDY AYACNTSTL AYAQKIFKI AYCLWMMLLISQAEAALELIT AYIDFEMKI AYSQQTRGL CDMLRLIDYNKAALS CINGVCWTV CLGGLLTMV CLIPTAMAF CLLPKMDSV CLPSPSTPV CLTSTVQLV CLYGNVEKV CMHLLLEAV CMTWNQMNL CPNSSIVY CRVLCCYVL CTDDNALAYY CTELKLSDY CTFEYVSQPFLMDLE CTPYDINQM CVNGVCWTV CYASGWGSI CYYASRTKL DENPVVHFFKNIVTPRTPP DIYKGVYQFKSV DLIFGLNAL DLMGYIPAV DLMGYIPLV DPRRRSRNL DRVNFKYSFSVIE DSDPDSFQDY DSVTPMILKAQKGGNL DVMNILLQYVVKSFDRSTKV DYLNEWGSRF DYLQYVLQI DYVDRFYKTLRAE EADPIGHLY EADPTGHSY EAWGALANWAVDSA EISTNIRQAGVQYSR EIYKRWII ELAGIGILTV ELEKYQQLNSERGVPN ELERAADVK ELFQDLSQL ELKRKMIYM ELMTLATWV ELRRKMMYM ELSDSLGPV ENIQRFLPNPAGVQLEDPEF EPDVYYTSAFVFPTK EPLPQGQLTAY EPR(PHOSPHO-S)PSHSM ESEFQAALSRKVAKL ETLLRAVESYLLAHS EVDPASNTY EVDPIGHLY EVYDFAFRDL EWVAEIRSKSINSAT EYCPGGNLF EYILSLEEL EYLNKIQNSLSTEWSPCSVT EYLVSFGVW EYRALQLHL EYYELFVNI FAPGNYPAL FAWERVRGL FFPSIRDLL FHTYTIDWTKDAVTW FIAGLIAIV FIASNGVKLV FIDSYICQV FLAEDALNTV FLAKLNNTV FLALIICNA FLDEFMEGV FLDKGTYTL FLDPRPLTV FLFLRNFSL FLGKIWPS FLGYLILGV FLHCIVFNV FLIIWQNTM FLKEKGGL FLLSLGIHL FLLTRILTI FLPSDFFPSI FLPSDFFPSV FLPSPLFFFL FLPWHRLFLL FLRGRAYGL FLTGNQLAV FLTPKKLQCV FLWGPRALV FLYALALLL FLYDDNQRV FLYTLLREV FMNKFIYEI FMVFLQTHI FNNFTVSFWLRVPKVSASHLE FQDAYNAAGGHNAVF FQPQNGQFI FRDYVDRFYKTLRAEQASQE FSNSTNDILI FTSDYYQLY FVGEFFTDV FVWLHYYSV FWRGENGRKTRIAYERMCNILKGK FYVYSRVKNLNSSRV GAALQIPFAMQMAYRF GAGSLQPLALEGSLQKRG GAVQNEVTL GEARKTFVEL GEEYLILSARDVLAV GEIYKRWII GEPGIAGFKGEQGPK GFKQSSKAL GFVFTLTVPSER GILGFVFTL GILTVSVAV GINAVAYYRGLDVSV GIVEQCCTSICSLYQ GKLYGI[cit]DV[cit]STRDR GLADQLIHL GLAPPQHLIRV GLCTLVAML GLFGDIYLA GLFGDIYLAI GLFKCGIAV GLIQLVEGV GLKILQLL GLLGASVLGL GLLSLEEEL GLMEEMSAL GLMKYIGEV GLPVEYLQV GLQDCTMLV GLQHWVPEL GLSNLTHVL GLSPNLNRFL GLSPTVWLSV GLSRYVARL GLYDGMEHL GNAYISVLAHYGKNG GPGHKARVL GPRLGVRAT GQIGNDPNRDIL GQTYHLIVDTDSLGNPSLSV GRAFVTIGK GRFGLATEK GRFGLATVK GSENLKSLY GTSGSPIADK GTSGSPIIDK GTSGSPIINK GTSGSPIINR GTSGSPIVDK GTSGSPIVDR GTSGSPIVNR GVLLWEIFSL GVLVGVALI GVRGRVEEI GVYAT[cit]SSAV[cit]L[cit]SSVPGVR GVYDGREHTV GWVKPIIIGHHAYGDQYRAT GWYRPPFSRVVH GWYRSPFSRAVH GWYRSPFSRVVH GYCTQIGIF GYKDGNEYI GYKVLVLNPSVAATL HCIRNKSVI HCIRNKSVIL HGIRNASFI HLSTAFARV HLVEALYLV HLYQGCQVV HNTNGVTAACSHE HNTQYCNL HPNIEEVAL HPRLAQRIL HPVAEADYFEY HSKKKCDEL HSTNGVTRIY HTTDPSFLGRY HTYTIDWTKDAVTWS HYLSTQSAL IAFTSEHSHFSLK IEDPPFNSL IFDS[cit]GNPTVEVDLF IGPGRAFYA ILAKFLHWL ILDDNLYKV ILDTAGREEY ILEDIVLTL ILGFVFTLTV ILGVLTSLV ILHDGAYSL ILHNGAYSL ILIRTGLLVI ILKEPVHGV ILLRDAGLV ILLVVVLGV ILLWQPIPV ILMWEAVTL ILNAMIAKI ILRGSVAHK ILSLELMKL ILSPFLPLL IMDQVPFSV IMPKAGLLI IMYNYPAM IMYNYPAML IPQSLDSWWTSL IPRRIRQGL IPSINVHHY IPYLDGTFY ISHNFCNL ISPNSVFSQWRVVCDSLEDYD ISQAVHAAHAEINEAGR ITDQVPFSV IVDCLTEMY IVDTVSALVY IVTDFSVIK IYNVGQVSI IYRRRLMKQDFSVPQLPHS IYSTVASSL IYTWIEDHF KAAGLFNAPASQLAR KASEKIFYV KASEYLQLV KAVYNFATC KAVYNFATM KCDICTDEY KCIEWEKAQHGA KCSRNRQYL KCYGVSPTK KEKGGLEGL KEKYIDQEEL KELKRQYEKKLRQ KFIIKRYTPNNEIDSF KGMAALPRLIAFTSEHSHFS KIADYNYKL KIFGSLAFL KITAEWLWK KIWEELSVL KLAEAIFKL KLCLRFLSK KLCPVQLWV KLFAAETLK KLFGTSGQKT KLGEFYNQMM KLGGALQAK KLHLYSHPI KLIANNTRV KLIDRTE(S)L KLMSSNSTDL KLPQLCTEL KLQCVDLHV KLQDASAEV KLQVFLIVL KLSGLGINAV KLSGLGLNAV KLTGDENFTI KLTPLCVTL KLVALGINAV KLVVVGADGV KLVVVGAVGV KLWAQCVQL KMLKEMGEV KNVLKVGRLSAEELM KPTLKEYVL KPYSGTAYNAL KPYSGTAYNSL KQSSKALQR KRWIILGLNK KRWIILGLNKIVRMYSPTSI KRWIIMGLNK KSDICTDEY KSMREEYRK KSPWFTTL KSVWSKLQSIGIRQH KTFDSEYIK KTFDSEYVK KTFDTEYQK KTFPPTEPK KTIAYDEEARR KTWGQYWQV KVAEELVHFL KVAELVHFL KVDDTFYYV KVDELAHFL KVLEHVVRV KVLEYVIKV KVPIKWMALESILRRRF KVPRNQDWL KVVEFLAML KVVRFDKL KYKNAVTEL KYNKANVFL KYTSFPWLL LCWGELMTLATWVGVN LEAAFNAEFNEIRRVLLEEN LEASFNYLKSPNFSK LEKTKKDL LGMSNRDFL LGPISGHVL LIAHNQVRQV LITGRLQSL LKEFTVSGNILTIRL LLAARAIVAI LLCYSCKAQV LLDFVRFMGV LLDTASALY LLDVAPLSL LLDVPTAAV LLEFYLAMPFATPME LLFGLALIEV LLFGYPVYV LLFNILGGWV LLGATCMFV LLGRNSFEV LLHETDSAV LLLAGLFSL LLLDRLNQL LLLEAVPAV LLLGLMILL LLLIWFRPV LLLLDVAPL LLLLTVLTV LLLTVLTVV LLMWEAVTV LLNQLQVNL LLRDAGLVKM LLRRYNVAKV LLSHGAVIEV LLVPTCVFLV LLWNGPMAV LLYDANYFL LLYNCCYHV LMAQEALAFL LMLGEFLKL LMWYELSKI LNIDLLWSV LPLKMLNIPSINVH LPLMRKAYL LPNWGKYVL LPSDFFPSV LPVSCPEDL LPVSPRLQL LPVVLENARILKNCVDAK LPWHRLFLL LPYLGWLVF LRQMRTVTPIRMQGG LSFLPSDFFPSVRDL LSYYKLGASQRVAGD LTDDRLFTCY LTFGWCFKL LTFNYRNL LTLGEFLKL LTQYFVQENYLEYRQVPG LVDVMPWLQY LVFGIELMEV LVFGIEVVEV LWWVNNQSLPVSP LYNTVATLY MAKTIAYDEEARR MAYRFNGIGVTQNVLY MEAIAKRLDACQDQLLELYE MEVTPSGTWL MGLKFRQL MHVSFVMAYPEMLAA MLAVFLPIV MLDLQPETT MLNIPSINV MLWGWREHV MPFATPMEA MPVGGQSSF MPYLIDFGL MSIYVYALPLKMLNI MSQIMYNYPAMMAHA MTEQQWNFAGIEAAA MTEQQWNFAGIEAAASAIQG MVWESGCTV NAGFNSNRANSSRSS NEGATIVE NEKYAQAYPNVS NFIRMVISNPAAT NFPYLVAYQATVCARA NKGAFKYIKPQSQFI NLFETPVEA NLLLQYGSFCTQLNR NLLLQYGSFCTQLNRAL NLNESLIDL NLVPMVATV NMFTPYIGV NPDIVIYQY NRAKQVIKL NTLEQTVKK NVWATHACV NYFEWPPHALLVRQ NYNYLYRLF NYQPVWLCL NYTLRVDCTPLMYSL PDDYSNTHSTRYVTV PGPLRESIVCYFMVFLQTHI PIVQLQGDSNCLKCFR PKYVKQNTLKLAT PLFDFSWLSL PLFQVPEPV PLQPEQLQV PLTSIISAV PPAYRPPNAPILSTL PRSPTVFYNIPPMPLPPSQL PSLTMACMAKQSQTP PTDNYITTY PVGRLVTVNPFVSVA PVSKMRMATPLLMQA PVSQMRMATPLLMRP PYLFWLAAI PYYVVDLSVRGM QAGFFLLTRILTIPQS QAKWRLQTL QALNTLVKQLSSNFGAI QDFTN[cit]INKLKNS QEIYMQHTYPISA QIKVRVDM QLCPICRAPV QLFEELQEL QLFNHTMFI QLGEQCWTV QLIRAAEIRASANLAATK QLLDGFMITL QLLIKAVNL QLMAFNHLI QLMPYGCLL QMARLAWEA QPEWFRNVL QPRAPIRPI QRNAPRITF QSLEIISRY QVLKKIAQK QVPLRPMTYK QVYSLIRPNENPAHK QYDPVAALF QYIKANSKFIGITEL QYIKWPWYI QYSDRRWCF RAHYNIVTF RAKFKQLL RARSVSPKL REISVPAEIL RGHNVNGVTAACSHE RGPGRAFVTI RGYVYQGL RIAAWMATY RIEPSWADVK RIKQKGIL RILGAVAKV RISTFKNWPK RLAEYQAYI RLARLALVL RLASFYDWPL RLDDDGNFQL RLGLQVRKNK RLGPTLMCL RLLFFAPTR RLLPLLALL RLLQETELV RLMNDMTAV RLNMFTPYI RLQEERTCKV RLQGISPKI RLQSLQTYV RLRAEAQVK RLRPGGKKK RLRPGGKKKY RLSSCVPVA RLTRFLSRV RLVDDFLLV RLWQELSDI RMFPNAPYL RMPEAAPPV RMVLASTTAK RNGYRALMDKSLHVGTQCALTRR RPHERNGFTVL RPPIFIRRL RPQGGSRPEFVKL RQIFGDYKTTIC RRLGRTLLL RSDSGQQARY RSPFSRVVHL RTELLKDAIGEGK RTF(S)PTYGL RTLDKVLEV RVA(PHOSPHO-S)PTSGV RVASPTSGV RVCEKMALY RVIDPRRCMK RVRAYTYSK RVSTVQQLTK RYCNLEGPPI RYLEFEALGF RYLKDQQLL RYLKNGKETL RYLRDQQLL RYNAQCQETI RYPLTFGW RYPLTFGWCY SADNNNSEY SAVSNLFYV SCLENFRAYV SDYYFSWL SEFSSLPSYAAFATA SERPQASGVYMGNLT SFHSLHLLF SFNCRGEFFY SGHNCGTCRPGWRGAACNQKILTVR SGIQYLAGLSTLPGNPAIASL SGPLKAEIAQRLEDV SGPSNTPPEI SGVENPGGYCL SIDWFMVTV SIIAYTMSL SIINFEKL SIIPSGPLK SIIVFNLL SILLRDAGL SILLRDAGLV SITEVECFL SIYRYYGL SKYVFENV SLADEAEVYL SLAMLDLLHV SLDDYNHLV SLEENIVIL SLFEPPPPG SLFGQRIEV SLFLGILSV SLFNTVATL SLGEQQYSV SLLFLLFSL SLLMWITQC SLLMWITQV SLLQHLIGL SLLTEVETPIRNEWGS SLNQTVHSL SLPPPGTRV SLQPLALEGSLQKRG SLQPLALEGSLQSRG SLSEKTVLL SLSRFSWGA SLTITSLLRRHNWITSCS SLVDVMPWL SLVKHHMYI SLYKFSPFPL SLYNTVATL SLYSFPEPEA SLYSYFQKV SMTR(S)PPRV SPGDLQTLALEVARQKRG SPIVPSFDM SPRWYFYYL SPSVDKARAEL SPSYVYHQF SQADALKYV SQLLNAKYL SQNRKDIKLIDVEMT SRYWAIRTR SSCSSCPLSK SSCSSCPLTK SSIEFARL SSLENFRAYV SSPKPWIYATSNLAS STHVNHLHC STLCQVEPV STLPETTVVRR STYGWNIVK STYGWNLVR SVGGVFTSV SVLAFRRL SVYAWNRKR SVYDFFVWL SYIGSINNI SYIPSAEKI SYMLQALCI SYRNEIAYL SYVNTNMGL SYVPSAEQI TASSYFTNMFATWSPSKARL TDEMIAQYTSALLAG TDLGQNLLY TENSGKDI TEWETGQI TFPDLESEF TIHDIILECV TIPPTAGILK TLADFDPRV TLAPATEPA TLDTLTAFY TLDYKPLSV TLEEITGYL TLFFQNGKVKVFQGNQDSFT TLHCDCEIL TLLFNILGGWVAA TLNAWVKVV TLPGYPPHV TLQDIVYKL TLVPQEHYV TLYAVATTI TMFEALPHIIDEVIN TMFPHIIVDV TMNGSKSPV TPEGIIPTL TPGPGVRYPL TPHPARIGL TPNQRQNVC TPRVTGGGAM TRATKMQVI TRFQTLLALHRSYLT TRRFLPQIL TSINFVKI TSLYNLRRGTALA TSRNNPFYFPSRRFSTRYGN TSRTLSYYKLGASQRVA TSYKFESV TSYVKVLHHMVKISG TTDPSFLGRY TTHYGSLPQKSQ TTLSRTSKK TTVRLRAYMNTPGLPVC TVFYNIPPMPL TVSEFLKL TVSGNILTIR TVYGAFDPLLAVAD TVYGFCLL TWTTCQSIAFPSKTSASIGS TYACFVSNL TYFQRVLIF TYFSLNNKF TYGPVFMCL TYGPVFMSL TYGWNIVKL TYGWNLVKL TYGWNLVRL TYLPTNASL TYQRTRALV TYVPANASL TYWPVVSDI VAAAPQVKYAVFEAALTKAI VGLLKAVESYLLA VGRNFTNL VIFDFLHCI VILTNPISM VIMPCSWWV VISNDVCAQV VIVMLTPLV VIYHYVDDL VLAELVKQI VLAGGFFLL VLAGVGFFI VLDFAPPGA VLDGLDVLL VLEETSVML VLEPPGARDV VLFGLGFAI VLGEAWRDQV VLHDDLLEA VLHKRTLGL VLLALLMAGL VLLLVTHYA VLMIKALEL VLNDILSRL VLPLTVAEV VLQELNVTV VLQMKEEDV VLSDFKTWL VLSVNVPDV VLTDGNPPEV VLVKSPNHV VLYRYGSFSV VMAGVGSPYV VMAPRTLIL VMAPRTLVL VMIG(S)PKKV VMNILLQYV VNHRFTLV VPGLYSPCRAFFNKEELL VPLDEDFRKY VPQYGYLTL VSDGGPNLY VSIDKFRIFCKALNPK VTEHDTLLY VTEPGTAQY VTNNTFTLK VVGAVGVGK VVLGVVFGI VVLSFELL VVNKGTGNLELVAVRKEQQQ VVVGADGVGK VVVGAVGVGK VVYDFLKL VWLSVIWM VYAGAMSGL VYALPLKML VYDFAFRDL VYDFFVWLHY VYFFLPDHL VYGFVRACL VYGGSKTSLYNLRRGTALAI VYIGDPAQL VYLKTNVFL VYLRVRPLL VYYLTRDPTTPLARAA VYYNWQYLL WLPKILGEV WLQYFPNPV WLSLKTLLSL WLSLLVPFV WMHHNMDLI WNRQLYPEWTEAQRLD WPLLLLLLALPQRAYAQ WVKQTPGRGLEWIGA WYWGPSLYSI YACFVSNLATGRNNS YAIDLPVSV YESYKFIPALEAAVK YIGEVLVSV YLEPGPVTA YLEPGPVTV YLFFYRKSV YLGSYGFRL YLIELIDRV YLISGDSPV YLKDQQLL YLLDLSTNHL YLLEMLWRL YLLPRRGPRL YLNDHLEPWI YLNKIQNSL YLNPSVDSV YLNRHLHTWI YLNTVQPTCV YLQHNEIQEV YLQLVFGIEV YLQPRTFLL YLQQNWWTL YLQVNSLQTV YLQWIEFSI YLSGADLNL YLSGANLNL YLVGNVCIL YLVSIFLHL YLWWVNNQSL YLYQWLGAPV YMCSFLFNL YMDDVVLGA YMDGTMSQV YMEHNNVYTV YMLDLQPET YMLDLQPETT YMNGTMSQV YPHFMPTNL YPLHEQHGM YSEHPTFTSQY YSSDNLYQM YTCPLCRAPV YTMDGEYRL YTSGPGIRY YVDFREYEYY YVDPVITSI YVLDHLIVV YVNTNMGLK YVNVNMGLK YYIPHQSSL YYSNVTATRLLSSTNS | -- All Applications -- AAV Adenovirus Allergy Aspergillus Autoimmunity BK Virus Bordatella Pertussis Cancer CMV COVID-19 / SARS-CoV-2 EBV Factor VIII HBV HCV HIV HIV/SIV HPV HSV HTLV Human Influenza JC Virus LCMV Listeria Malaria Minor Histocompatibility Antigen Model Antigens Model Antigens / Other Mouse Multiple Sclerosis MuLV Negative Other RSV Sendai Virus SV40 Virus Tetanus Therapeutic Antibodies Toxoplasma gondii Trypanosoma cruzi Tuberculosis Vaccinia Virus Varicella Zoster Virus Vesicular Stomatitis Virus West Nile Virus Yellow Fever Virus Chlamydia Dengue HAV Helicobacter pylori Norovirus | -- All Epitope Origins -- 1116-1124 131-139 16 kDa 165-173 19 kDa 194-202 20-28 207-215 691-700 AAV VP1 492-500 AAV2 372-380 ACPP 299-307 Ad5 E1A 234?243 Adenovirus 5 Hexon 37-45 Adenovirus 5 Hexon 886-894 Adenovirus Hexon 114-124 AdV Hexon Alder pollen Aln g 1 142-154 Alder pollen Aln g 1 76-88 ASP-2 320-327 Aspergillus fumigatus Asp f 9 171-185 BA46 (Lactadherin) 97-106 BCL-2 180-189 Bcl-2 208-217 Bcl-2 214-223 Bcl-2 85-93 Bcl-X 173-182 BCR-ABL bcr-abl 210 kD fusion protein 19-27 bcr-abl 210 kD fusion protein 21-29 bcr-abl 210 kD fusion protein 259-269 BHRF1 122-133 Birch pollen allergen Bet v 1 142-156 Birch pollen Bet v 1 141?155 BKV Ltag 406-414 BKV Ltag 579-587 BMI1 271-279 BMI1 74-82 BPLF1 1395-1407 BRAF 594-601 (600E) BRAF 594-601 (600V) BRLF1 BRLF1 109?117 bZIP factor 10-18 bZIP factor 26-34 CA9 219-227 Carcinoembryonic antigen (CEA)-derived peptide CAP1-6D Carcinogenic Embryonic Antigen (CEA) 571-579 Carcinogenic Embryonic Antigen (CEA) 652-660 Carcinogenic Embryonic Antigen (CEA) 694-702 Cat dander Fel d 1 53-70 CB9L2 CD20 188-196 (B cell malignancies) CD33 65-73 (1Y2L) CD59 glycoprotein precursor 106-114 CDH3 807-816 CEA 321-333 CEA 653-667 CEACAM 185-193 Chondromodulin-I 319-327 circadian clock protein PASD1 691-700 cit aggregan 89-103 cit alpha-enolase 11-25 cit CILP 297?311 cit CILP 982?996 cit fibrinogen-alpha 79-91 cit vimentin aa 59-78 CLIP 87-101 CMV IE-1 199-207 (R/L Position 3 CMV IE-1 248-256 core 158-172 core 45-59 Cow dander Bos d 2 143-158 CSP 326-345 CYP190 Cytochrome p450 1B1 239-248 DEP DC1 294-302 DLK1 309-317 Dog dander Can f 1 33-48 DRRFY (1521-1529)) E. coli beta-galactosidase 876-884 E2 285-300 E2 5-17 EBNA1 509-528 EBNA2 11-30 EBNA2 276-295 EBNA3B 399-408 EBV BALF-4 276?284 EBV BMLF-1 259-267 EBV BMRF1 116-128 EBV BMRF1 208-216 EBV BNRF1 1395-1407 EBV BRLF1 134-142 EBV BZLF-1 190-197 EBV BZLF-1 54-64 EBV EBNA-1 407-417(4A) EBV EBNA-3A 193-201 EBV EBNA-3A 247-255 EBV EBNA-3A 458-466 EBV EBNA-3C 284-293 EBV EBNA-3C 881-889 EBV EBNA-4 416-424 EBV EBNA1 482-496 EBV EBNA1 515-527 EBV EBNA1 551-570 EBV EBNA2 280-290 EBV EBNA3A 158-166 EBV LMP-1 125-133 EBV LMP-2 340-349 EBV LMP-2 356-364 EBV LMP-2 419-427 EBV LMP-2 426-434 EBV LMP2 131-139 EBV LMP2 200-208 EBV LMP2 419?427 EGF-R 1138-1147 EGF-R-479 350-359 Enhanced Green Fluorescent Protein (eGFP) 200-208 Env 586-593 ENV EBNA 3A 603?611 envelope 179-194 EphA2 Epithelial Discoidin Domain Receptor 1 (EDDR1) 867-876 ESAT-6 Ewing Tumor EZH2 666-674 EZH2 729-737 Factor VIII 589?608 FAP 639-647 FAP alpha 463-471 Flu BNP 85-94 (Influenza B) FOXM1 262-270 G250 (renal cell carcinoma) 217-225 GAD65 113-132 GAD65 114-123 GAD65 265?284 GAD65 274-286 GAD65 555-567 gag 163-182 Gag 433-440 gB 215-229 gp100 gp100 (pmel) 209-217 gp100 (pmel) 280-288 (288V) gp100 (pmel17) 154-162 gp100 (pmel17) 17-25 gp100 (pmel17) 209-217 gp100 (pmel17) 25-33 gp100 (pmel17) 476-485 gp100 44-59 gp100 615-633 gp100-intron 4 (170-178) gp33 (C9M) GPC3 144-152 (overexpressed in hepatocellular carcinoma) GPC3 298-306 Grass pollen allergen Phl p 5 196-210 HA-2 HBV core 117-125 HBV core 18-27 (subtype ADR4) HBV core 93-100 HBV core antigen 18-27 HBV core antigen 88-96 HBV envelope 183-191 HBV polymerase 573-581 HBV polymerase 756-764 HBV surface antigen 172-181 HBV surface antigen 185-194 HBV Surface antigen 190-197 HBV surface antigen 208-216 HBV surface antigen 28-39 HBV? core? 60-75 HCMV IE1 184-192 HCMV IE1 316-324 (UL123) HCMV IE1 81-89 HCMV pp50 245-253 HCMV pp65 113-121 HCMV pp65 123-131 HCMV pp65 265-275 HCMV pp65 341-349 HCMV pp65 363-373 HCMV pp65 417-426 HCMV pp65 495-504 HCV core 111-119 HCV core 132-140 HCV core 35-44 HCV core 41-49 HCV E1 207-214 HCV NS2 47-63 HCV NS2 732-753 HCV NS3 1031-1039 HCV NS3 1073-1081 HCV NS3 1359-1367 HCV NS3 1395-1403 HCV NS3 1406-1415 HCV NS3 1435-1443 HCV NS3 1436-1444 HCV NS3 1629-1637 HCV NS4b 1807-1816 HCV NS5a 1957-1975 HCV NS5a 1987-1995 HCV NS5a 2266-2275 HCV NS5B 2588-2596 HCV NS5b 2594-2602 HCV NS5B 2727-2735 Heme oxygenase-1 212-220 HENMT1 221-229 HER-2 434-443 HER-2/neu (85?94) HER-2/neu 369-377 HER-2/neu 435-443 HER-2/neu 63-71 HER-2/neu 689-697 HER2 883-899 Histocompatibility antigen 60 39-46 HIV env HIV env 382-391 HIV gag 77-85 HIV gag 79-86 HIV gag p24 HIV gag p24 197-205 HIV gag p24 223?231 HIV nef HIV nef 84-92 HIV p24 gag 128-135 HIV Pol HIV pol 325-333 HIV Vif 23-31 HIV Vpu 66-74 HIV-1 env gp120 848-856 HIV-1 env gp120 90-98 HIV-1 gag 263-282 HIV-1 gag 293-312 HIV-1 gag 295-307 HIV-1 gag gp41 67-75 HIV-1 gag p17 19-27 HIV-1 gag p17 76-84 HIV-1 gag p24 19-27 HIV-1 gag p24 199-207 HIV-1 gag p24 261-269 HIV-1 Gag p24 263-272 HIV-1 gag p24 265-274 HIV-1 gp100 103-111 HIV-1 HIV-1 RT 273-282 HIV-1 HIV-1 RT 328-336 HIV-1 IIIB gp120 318-327 HIV-1 nef 128-137 HIV-1 Nef 134-143 HIV-1 Nef 137-145 HIV-1 nef 73-82 HIV-1 nef 90-97 HIV-1 Nef 92-100 HIV-1 p17 20-29 HIV-1 RT 476-484 HIV-1 US4 gp120 318-326 HIV-1 Vif 101-109 HLA-A leader sequence peptide HLA-C leader sequence peptide HLA-Cw3 170-179 HM1.24-aa 126-134 hMena 502-510 HMOX1 145-153 House dust mite Der p1 251-265 House dust mite Der p1 96-110 hPSA HPV 16 E6 18-26 HPV 16 E7 11-20 HPV 16 E7 12-20 HPV 16 E7 49-57 HPV 33 E6 64-72 HPV 33 E7 5-13 HPV 33E6 86-94 HPV E2 1-20 HPV E6 48-57 HPV E7 11-19 HPV L1 165-173 HPV16 E6 HSP105 128-136 HSP105 234-243 HSP90 alpha 280-288 (Pathologic Conditions) HSV p56 487-495 HSV-1 gp B 498-505 HTLV bZIP factor 42-50 Human alfa fetoprotein 158-166 Human Mena protein (overexpressed in breast cancer) Human T-cell lymphotropic virus-1 Tax 11-19 Human T-cell lymphotropic virus-1 Tax 301-309 IA-2 797-805 IA-2 805-813 IE1 199-207 IE62 593-601 IL13r 146-154 IL13R 345-353 iLR1 iLR1 59-68 Infliximab Heavy chain 46-60 Influenza A (NT60) NP 366-374 Influenza A (PR8) NP 147-155 Influenza A (PR8) NP 265-274 Influenza A (PR8) NP 366-374 Influenza A (PR8) NP 44-52 Influenza A (PR8) Polymerase acidic protein 224-233 Influenza A HA 307-319 Influenza A HA 533-541 Influenza A MP 17-31 Influenza A MP 58-66 Influenza A MP 59-68 Influenza A MP 61-72 Influenza A MP1 178-187 Influenza A MP2 70-78 Influenza A NP 206-229 Influenza A NP 383-391 Influenza A NP 473-481 Influenza A PB1 329-337 Influenza A PB1 591-599 Influenza A polymerease PA 224-233 Insulin B chain 10-18 Insulin receptor substrate 2 Insulin receptor substrate-2 1097-1105 Interferon gamma inducible protein (GILT) 30 27-35 IRS-2 1097-1105 ITGB8 662-670 KIF20A 67-75 KSHVF-8 gB.492-500 LAGE-1 46-54 LCMV envelope gp 10-18 LCMV envelope gp 447-455 LCMV GP 118-125 LCMV GP 276-286 LCMV GP1 33-41 LCMV NP 396-404 Leptospira Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177 Listeria monocytogenes Listeriolysin 91-99 Livin/ML-IAP280 175-184 LMP1 159-167 Lymphocyte antigen 6 complex locus K (LY6K) 177-186 M. tuberculosis CFP-10 71-85 M/I Position 7) MAGE-A1 161-169 MAGE-A3 MAGE-A3 168-176 MAGE-A3 267-282 MAGE-A3 281-295 MAGE-A4 230?239 MAGE-A6 102-116 MAGE-A6 246-263 MAGE-C1 1083-1091 MAGE-C2 191-200 MAGE-C2 336-344 MAGEA-10 254-262 MAGEA1 278-286 MAGEA2 157-166 MAGEA3 112-120 MAGEA3 112-120 (alternative version) MAGEA3 271-279 MAGEA3 97-105 MAGEA5 5-12 MART-1 51-73 MC-38 MC28 adpgk neoantigen Mcl-1 95-103 MCMV IE1 168-176 MCMV M139 419-426 MCMV m145 451-459 MCMV m164 257-265 MCMV m45 985-993 MCP 1264-1281 MelanA / MART 26-35 MELK 87-95 (93N) Mesothelin 429-437 Mesothelin 530?538 MHV 524-431 Midkine 110-119 MiHA ACC1 15-23 miHAg H-Y (human SMCY) 311-319 miHAg HA-8 MiHAg SMCY 1041-1051 miHAg SMCY 738-746 miHAg UTY 246-254 Minor Histocompatibility Antigen HA-1 137-145 MOG 97-109 MOG Precursor 69-78 Moloney murine sarcoma virus (MoMSV) GagL 85?93 MPP11 Mtb 10 kDa chaperonin GroES Mtb ESAT-6 like protein Mtb ESAT6 1-15 Mtb ESAT6 1-15? Mtb groEL 1-13 Mtb groEL 3-13 Mtb groEL 3-13?? Mtb PE family protein Mtb85A 145-152 mTERT mTERT 572-580 MUC-1 12-20 muFAP? 289-296 Mugwort pollen Art v 1 25-36 MuLV env 622-629 MuLV env gp70 423-431 Murine Survivin 20-28 Murine Survivin 97-104 Mybpc2 295-302 Mycobacterium bovis antigen 85-A 200-208 Mycobacterium bovis antigen 85-A 6-14 Mycobacterium tuberculosis Ag85A 70?78 Mycobacterium tuberculosis ESAT-6 17-25 Mycobacterium tuberculosis TB10.4 4-11 Mycobacterium tuberculosis TB10.4 4-12 Myelin basic protein 110-118 Myelin basic protein 83-101 Negative Control Neu/Her-2/Erbb2 proto-oncoprotein 66-74 Non muscle Myosin-9 741-749 Non-muscle Myosin 478-486 NP 69-77 NPM1 NRP-V7 superagonist peptide 8.3 Tg NOD mouse NS3 NS4b NS4B 214-222 NS5b NS5B 2841-2849 NY-ESO-1 123-137 NY-ESO-1 127-136 NY-ESO-1 157-165 NY-ESO-1 157-165 (9C) NY-ESO-1 87-101 NY-ESO-1 87-111 NY-ESO-1 94-102 Osteocalcin 51-60 Ovalbumin (subdominant) 55-62 Ovalbumin 257-264 P2X5 p31-39 p53 103-111 p53 139-147 p53 149-157 p53 187-197 p53 264-272 p53 65-73 PASD1 168-176 PASD1 39-48 PASD1 695-703 PAX-5 311-319 Peanut Ara h 1 169-188 Peanut Ara h 1 321-340 Peanut Ara h 1 457-476 Pertussis toxin subunit 2 129-144 Plasmodium berghei ANKA acid phosphatase 40-48 Plasmodium berghei CSP 252-260 Plasmodium CSP Plasmodium falciparum CSP 334-342 Plasmodium falciparum Liver stage antigen 1671-1679 PLP 180-199 PLP 98-109 Pol 502-510 Polyoma virus middle T protein 389-397 polyprotein 1248-1262 polyprotein 1411?1425 polyprotein 1582?1597 polyprotein 1770-1790 polyprotein 1806?1818 polyprotein 2800-2815 pp65 109-123 pp65 116-129 pp65 120-128 pp65 15-23 pp65 177-191 PRAME PRAME 100-108 PRAME 425-433 PRAME PRA 300?309 Preproinsulin 76-90 88S Proinsulin 73-90 Proinsulin 90-104 Proinsulin precursor 15-24 Prominin1 744-752 Prostate Specific Antigen 146-154 Prostate Specific Antigen-1 (PSA-1) 141-150 Prostate Specific Antigen-1 (PSA-1) 154-163 Prostate Specific Antigen-1 153-161 Prostate Stem Cell Antigen (PSCA) 105-133 Prostate Stem Cell Antigen (PSCA) 14-22 Prostatic acid phosphatase precursor (PAP) 299-307 Prostatic Acid Phosphatase-3 (PAP-3) Prostatic Acid Phosphatase-3 (PAP-3) 135-143 PSA 65-73 PSCA 44-51 (51A) PSM P2 (prostate) PSMA 27-38 PSMA 459-473 PSMA 85-93 PSMA/PSM-P1 4-12 Receptor for hyaluronic acid?mediated motility (RHAMM) 165-173 RhoC 176-185 (177L) Rituximab Heavy chain 36-50 Rituximab Light chain 41-55 RNF43 11-20 RNF43 721-729 (722Y) RSV A strain F protein 85-93 RSV M2 82-90 RSV NP 137-145 Rye grass Lol p1 124-136 SARS-CoV Nucleocapsid protein 223-231 (conserved in SARS-CoV-2) SARS-CoV-2 Nucleocapsid protein 362-370 (confirmed epitope) SARS-CoV-2 Spike 236-250 SART3 309-317 SART3 315-323 Sendai virus NP 324-332 SIV gag SIV Gag 181-189 SIV Gag 71-79 SIV Nef 159-167 SMCY 1332-1339 SSA SS-56 55-64 STEAP 292-300 (293L) Survivin 80-88 Survivin 96-104 Survivin-3A 18-27 (27K) Survivin-3A 96-104 SV40 T antigen 404-411 Synthetic epitope PADRE Synthetic variant of VSV Nucleoprotein 498?505 T1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13 T1D Diabetes IGRP 228?236 T1D Diabetes IGRP 265-273 TACE 250-258 TARP(P5L) 5-13 TARP(V28L)27-35 Telomerase 540-548 Telomerase reverse transcriptase (hTRT) 461-469 Telomerase Reverse Transcriptase (hTRT) 615-624 Telomerase Reverse Transcriptase (hTRT) 674-683 Telomerase Reverse Transcriptase (hTRT) 988-997 Telomerase Reverse Transcriptase 865-873 Tetanus Toxin 257-269 tgd057 57-64 Timothy grass Phl p 5 p26 TNPO3 Topoisomerase II-alpha-b 828-836 TPBG 258-266 TRAG-3 4-12 TRAG-3 57-66 Trypanosoma cruzi ASP-2 553-560 Trypanosoma cruzi SP 536-543 TT 1084-1099 TT 1174-1189 TT 1273-1284 TT 830-844 TT 947-967 TTK protein kinase 551-559 Tumor Mucin Antigen 13-21 Tumour Antigen P815 35-43 type II collagen (CII) 256-270 Tyrosinase 188-196 Tyrosinase 208-216 Tyrosinase 243-251 (244S) tyrosinase 365-381 Tyrosinase 368-376 Tyrosinase 369-377 (371D) Tyrosinase related protein-2 180-188 Tyrp1 277-297 Vaccinia virus Copenhagen Protein G5 18-26 Vaccinia virus Host range protein 2 74-82 Vaccinia virus WR epitope B8R 20-27 VEGFR2 400-408 VEGFR2/KDR fragment 1 614-624 Vinculin 822-830 VP1 100-108 VP1 108-116 VP1 36-44 VSV N 275-283 VSV NP 52 West Nile Virus NY-99 polyprotein precursor (1452-1461) West Nile virus NY-99 polyprotein precursor 2023-2031 West Nile virus NY-99 polyprotein precursor 3390-3398 West Nile Virus polyprotein 294-302 WT-1 126-134 (Wilms tumor) WT1 WT1 187-195 WT1 235-243 Yellow Fever Virus 17D polyprotein 268-275 4 NS5 2611-2619 5T4 97–105 5T4 97x96105 ACTN4 118-127 (K5N) Ad5 E1A 234–243 AIM-2 Alpha papillomavirus 9 E6 Protein (22-31) Alpha-fetoprotein isoform 1 137-145 Alpha-fetoprotein isoform 2 167-176 Ankyrin NYBR1 158-167 Aspergillus fumigatus Crf1/p41 170-184 BIR BIR 7 230-239 BIR7 90-99 BRLF1 109–117 CAMEL 2-11 CEA 176-185 CEACAM5 687-695 Chicken ovalbumin 323-339 chicken ovalbumin 329-337 Chlamydia trachomatis MOMP 258-266 Core 141-151 Core 19-27 Core 30-38 Core 87-95 Core 88-96 core protein 23-31 core protein 64-72 CSNK1A1 26-34 CSNK1A1 26-35 cyclin-dependent kinase 4 170-178 Cyclin-dependent kinase inhibitor 1 97-105 CyclinD 101-109 CyclinD 228-236 Cysteine-rich membrane protein 63-71 Cytochrome P450 240-249 Cytochrome P450 246-254 DBY 608-622 Dengue C 107-115 Dengue C 22-31 Dengue NS2b 52-60 Dengue NS2b 97-106 Dengue NS3 112-120 Dengue NS3 133-142 Dengue NS3 25-32 Dengue NS3 422-431 Dengue NS3 500-508 Dengue NS3 528-537 Dengue NS3 557-565 (Singapore/S275/1990) Dengue NS3 64-74 Dengue NS3 serotype 2 133-142 Dengue NS3 serotype 2 222-231 Dengue NS3 serotype 3&4 133-142 Dengue NS4a 56-64 Dengue NS4a 6-13 Dengue NS4b 111-119 Dengue NS4b 40-48 Dengue NS5 375-383 Dengue NS5 563-571 DENV 1 DENV 1 NS3 1864-1872 DENV 1 NS5 2610-2618 DENV 2 Core 58-67 DENV 2 M 261-269 DENV 2 NS2a 1336-1344 DENV 2 NS3 1608-1617 DENV 2 NS3 1863-1871 DENV 2 NS5 2608-2616 DENV 2 NS5 2609-2617 DENV 2 Polyprotein 1863-1871 DENV 2 Polyprotein 2315-2323 DENV 3 NS5 2607-2615 DENV 3 NS5 2608-2616 DENV 3 NS5 2971-2980 DENV 4 NS3 1607-1617 Desmuslin 426-434 Dickkopf-related protein 1 20-29 EBNA-1 (562-570) EBV BALF-4 276–284 EBV LMP2 419–427 Endophilin-B2 244-252 ENV EBNA 3A 603–611 EPHA2 550-558 ETV5 54-53 EWS-FLI-1 oncogene external core Ag Factor VIII FGFR4 676-684 Fibromodulin 206-215 Fibromodulin 250-259 Fibromodulin 7-15 FLT3 ITD FSP26 GAD2 339-352 GAS7 Neoepitope Genome Polyprotein HAUS3 154-162 HBV Pol 455-463 HCA587 317-325 HCV NS3 1535-1551 Helicobacter hepaticus HH1713 230-244 Heparanase 185-193 Heparanase 8-16 Hepatitis A Virus polyprotein 1877-1885 Hepatitis A Virus polyprotein 2027-2034 Hepatocyte growth factor receptor 673-681 HER-2/neu (85–94) HER-2/neu 789-797 HER2 466-474 Histocompatibility Antigen I-Ag7 from Mus Musculus Chain A. HIV Env gp 67-7 HIV gag p24 223–231 hnRNP L 140-148 hnRNP L 404-412 HSP1A 459-467 HSP1A 461-469 Human class II-associated invariant chain peptide (CLIP) 103-117 Human clotting factor VIII 2210-2229 I-E alpha chain (2W1S) 52-68 IAd Influenza A HA 141-155 IAd Influenza A HA 143-155 IAd Influenza A M2 2-17 IAd LCMV NP 116-130 (P8) IAd LCMV NP 86-100 IE1 309-317 IE1 88-95 IGRP (206-214) Influenza A MP 13-21 Influenza A nucleocapsid protein 311-325 Insulin Precursor 76-90 isocitrate dehydrogenase [NADP] cytoplasmic (IDH1)(123-142) KRAS G12D (5-14) KRAS G12D (7-16) KRAS G12V(5-14) KRAS G12V(7-16) KRAS G12V(8-16) L-dopachrome tautomerase 288-296 L-dopachrome tautomerase 488-496 large envelope 362-371 large T antigen 398-406 large T antigen 410-418 Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177 Listeriolysin O precursor 190-201 LMP2_EBVG 339-348 LSP1 325-333 LT antigen 27-35 Lymphocytic choriomeningitis virus glycoprotein 316-330 Lymphocytic choriomeningitis virus glycoprotein 6-20 Lymphocytic choriomeningitis virus glycoprotein 66-77 Lymphocytic choriomeningitis virus nucleoprotein 176-190 Lymphocytic choriomeningitis virus nucleoprotein 466-480 M. tuberculosis antigen 85B precursor 280-294 M. tuberculosis RplJ 140-164 MAGE-A4 169–177 MAGE-A4 169x96177 MAGE-A4 230–239 MAGEA12 160-169 MAGEA2 153-161 MAGEA3 MAGEA3 160-169 MAGEA3 220-228 MAGEA9 223-231 Malic enzyme 224-232 MART-1 56-64 MCL-1 139-147 Mcl-1 177–185 Mcl-1 177x96185 Melanocyte-specific secreted glycoprotein 184-193 Melanocyte-specific secreted glycoprotein 20-28 Melanoma-associated antigen 4 (MAGE4) 113-121 Melanoma-associated antigen 4 (MAGE4) 286-294 Membrane-associated transporter protein Mesothelin 530–538 MG50 1051-1059 MG50 1244-1252 MG50 210-218 MG50 624–632 MG50 624x96632 MG50 625-633 MG50 69-77 Mimotop of Chain A Mimotope of Chain A Minor antigen HA-3T (Lbc oncogene 451-459) MOG 38-49 var S42P MOG 38-49 var V47A Moloney murine sarcoma virus (MoMSV) GagL 85–93 MOMP precursor 283-291 mouse MBP 63-74 Mouse myelin oligodendrocyte glycoprotein 38-49 mouse ProInsulin 47-64 Mucin 79-87 Mucin2 467-475 Mucin2 645-653 murine class II-associated invariant chain peptide (CLIP) 86-100 Mutant anaplastic lymphoma kinase 1220-1229 Mycobacterium tuberculosis Ag85A 70–78 N-ras 55-64 Norovirus VP1 139-148 NS3 205-213 NS3 serotype 1 133-142 O-linked N-acetylglucosamine transferase FSP06 PAX3/FKHR 135-143 PLEKHM2 Polymerase 548-556 POMP 612-620 pp65 211-219 PqqC-like protein 70-78 PRAME (432-440) PRAME PRA 300–309 Probable ATP-dependent Clp protease ATP-binding subunit 7-15 Prostate stem cell antigen 4-13 PSCA PSCA 17-26 PSMA Rabies Glycoprotein (453-461) Receptor for hyaluronic acid–mediated motility (RHAMM) 165-173 Receptor tyrosine-protein kinase erbB-2 437-445 Receptor tyrosine-protein kinase erbB-2 448-456 Receptor tyrosine-protein kinase erbB-2 48-56 Receptor tyrosine-protein kinase erbB-2 707-715 Receptor tyrosine-protein kinase erbB-2 728-736 Receptor tyrosine-protein kinase erbB-2 743-751 Receptor tyrosine-protein kinase erbB-2 819-828 Receptor tyrosine-protein kinase erbB-2 845-853 Receptor tyrosine-protein kinase erbB-4 890-898 Respiratory syncytial virus matrix protein 2 26-39 Respiratory syncytial virus matrix protein M 209-223 RHAMM 275-283 RNF43 11-19 SARS-CoV S protein (873-888) (conserved in SARS-CoV2) SARS-CoV S protein (884-899) (conserved in SARS-CoV2) SARS-CoV S protein (939-955)(conserved in SARS-CoV2) SARS-CoV S protein (993-1010) (conserved in SARS-CoV2) SARS-CoV Spike glycoprotein precursor 1174-1182 (conserved in SARS-Cov-2) SARS-CoV Spike glycoprotein precursor 940-948 (conserved in SARS-CoV-2) SARS-CoV Spike glycoprotein precursor 958-966 (conserved in SARS-Cov-2) SARS-CoV-2 Env 56-70 SARS-CoV-2 gp 176-190 SARS-CoV-2 Nucleocapsid protein 105-113 (confirmed epitope) SARS-CoV-2 Nucleocapsid protein 322-330 (confirmed epitope) SARS-CoV-2 Nucleocapsid protein 9-17 SARS-CoV-2 ORF1ab 1641-1651 SARS-CoV-2 ORF1ab 2211-2225 SARS-CoV-2 ORF1ab 3886-3894 (confirmed epitope) SARS-CoV-2 ORF1ab 3948-3962 SARS-Cov-2 ORF1ab 4163-4172 SARS-CoV-2 ORF1ab 5455-5463 SARS-CoV-2 ORF1ab 5563-5571 SARS-CoV-2 ORF1ab 5724-5732 SARS-CoV-2 ORF1ab 5781-5789 SARS-CoV-2 ORF1ab 808-816 SARS-CoV-2 ORF3a 139-147 (confirmed epitope) SARS-CoV-2 ORF3a 207-215 (confirmed epitope) SARS-CoV-2 ORF7a 78-86 SARS-CoV-2 Replicase polyprotein 1ab 1621-1629 (confirmed epitope) SARS-CoV-2 Replicase polyprotein 1ab 1637-1646 (confirmed epitope) SARS-CoV-2 Spike glycoprotein 1000-1008 (confirmed subdominant epitope) SARS-CoV-2 Spike glycoprotein 1205-1213 SARS-CoV-2 Spike glycoprotein 1220-1228 (confirmed epitope) SARS-Cov-2 Spike glycoprotein 269-277 (confirmed epitope) SARS-CoV-2 Spike glycoprotein 378-386 SARS-CoV-2 Spike glycoprotein 448-456 SARS-CoV-2 Spike glycoprotein 691-699 SARS-CoV-2 Spike glycoprotein 751-765 SARS-CoV-2 Spike glycoprotein 751-767 SARS-CoV-2 Spike glycoprotein 866-880 SARS-CoV-2 Spike glycoprotein 996-1004 (confirmed epitope) SARS-CoV-2 Spike Protein (S) 417-425 SARS-CoV-2ÿ Membrane glycoprotein 172-188? SARS-CoV2 Spike Protein (S) 166-180 SFRS2B 241-249 SOX11 266-275 Spike 349-357 Spike 505-523 SSX2 103-111 SSX2 41-49 STEAP 86-94 Streptococcus pyogenes Cas9 615-623 Synthetic variant of VSV Nucleoprotein 498–505 T1D Diabetes IGRP 228–236 Tensin3 1558-1566 TERT UPC2 (578-592) Thymidylate synthase 231-240 TRAG-3L 58-66 TRAP 45-54 TRAP 57-65 TRAP 59-68 Trophoblast glycoprotein 17-25 TRP-2 181-190 TRP2 185-193(L) TRPM8 187-195 Tubulin beta 4 283-291 Tyr A1a 454-463 Tyrosinase 207-216 Tyrosinase 243-251 Tyrosinase 482-190 Tyrosinase precursor 224-233 tyrosinase-related protein 1 1106-130 VEGFR1 28-37 VP1 44-52 West Nile Virus envelope protein 641-655 Wilms Tumor protein (221- 229) Wilms Tumor Protein 83-91 WNV envelope gp 430-438 WNV nonstructural protein 4B 15-23 X 92-100 |
Show products per page
Page 1 of 1
| Allele | Peptide Code | Peptide Sequence | Application | Epitope Origin | Configuration | Qty | Price |
|---|